2025 Annual Meeting | C109 - Core Concepts in Pain Management: Safe and Appropriate Opioid Prescribing in Neurology

Date Monday 04/07/25

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Nicholas J. Silvestri, MD, F�鶹��ýӳ��

Topic(s) Pain

Learning Objectives Participants should understand the principles and challenges behind the management of neuropathic pain related to peripheral nervous system disorders; the cascade of neuropathic pain mechanisms, the rationality of combination therapy to address different mechanisms of action, and costs related to opiate use and painful diabetic neuropathy; and pharmacological and alternative approaches in managing these challenging patient issues.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 02:00 PM PDT	Speaker	Safe and Appropriate Opioid Prescribing in Neurology Varun Sreenivasan, MD
02:00 PM - 03:00 PM PDT	Speaker	Medical Treatment of Neuropathic Pain Nicholas J. Silvestri, MD, F�鶹��ýӳ��

Faculty Disclosures
Nicholas J. Silvestri, MD, F�鶹��ýӳ��	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of an immediate family member of Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Varun Sreenivasan, MD	The institution of Dr. Sreenivasan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ITF therapeutics.